Taurolidine-based lock solutions for hemodialysis catheters: the enthusiasm should be tempered
(2018) Kidney International — Vol. 93, n° 4, p. 1015-1016 (2018)
Files
LabriolaTaurolidine-basedlocksolutionsforhemodialysiscatheters_th.pdf
Open Access - Adobe PDF
- 50.13 KB
Details
- Authors
Labriola, Laura 
- Abstract
- (en) To the Editor: In a recent single-blind, randomized controlled trial, Winnicki et al.1 showed that the use of taurolidine-based catheter lock solutions (taurolidine-citrate-heparin twice weekly and taurolidine-citrate-urokinase once weekly) significantly reduced the incidence of catheter-related bacteremia (CRB) (incidence risk ratio, 0.25; 95% confidence interval, 0.10–0.73; P = 0.009) and catheter malfunction (P = 0.001 for both reversal of catheter lines and need for thrombolytics) compared with citrate 4%. […]
- Affiliations
Citations
Labriola, L., & Jadoul, M. (2018). Taurolidine-based lock solutions for hemodialysis catheters: the enthusiasm should be tempered. Kidney International, 93(4), 1015-1016. https://doi.org/10.1016/j.kint.2018.01.018 (Original work published 2018)